IL22 and serum lipopolysaccharide activity: Various types of obese (db/db, ob/ob, and DIO) mice showed a dramatic reduction in IL-22 production from colonic innate lymphoid cells (ILCs) and Tregs upon infection with enteric pathogen Citrobacter rodentium, and IL-22 treatment reversed the endotoxemia-induced chronic inflammation and insulin resistance [89].